⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL285689 | 0.84 | — | — | |
| SCHEMBL3138187 | 0.80 | TSHR (0.39) | — | |
| SCHEMBL3142403 | 0.80 | TSHR (0.39) | — | |
| SCHEMBL3144028 | 0.80 | TSHR (0.39) | — | |
| SCHEMBL1379941 | 0.80 | — | — | |
| SCHEMBL3146489 | 0.80 | TSHR (0.39) | — | |
| SCHEMBL127435 | 0.76 | — | — | |
| SCHEMBL2007584 | 0.71 | — | — | |
| SCHEMBL16569589 | 0.60 | — | — | |
| SCHEMBL689737 | 0.60 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1692 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4385980-A1 | INDAZOLES AS INHIBITORS OF NAV1.8 | Grünenthal GmbH (DE) | 2024-06-19 | — | — | EP | claimed |
| EP-4376819-A1 | USE OF SGLT-2 INHIBITORS FOR THE PREVENTION AND/OR TREATMENT OF HYPERTENSION IN NON-HUMAN MAMMALS | Boehringer Ingelheim Vetmedica GmbH (DE) | 2024-06-05 | — | — | EP | claimed |
| EP-4376829-A1 | USE OF SGLT-2 INHIBITORS FOR THE PREVENTION AND/OR TREATMENT OF CARDIAC DISEASES IN NON-HUMAN MAMMALS EXCLUDING FELINES, IN PARTICULAR CANINES | Boehringer Ingelheim Vetmedica GmbH (DE) | 2024-06-05 | — | — | EP | claimed |
| EP-4378936-A1 | BIFUNCTIONAL CHIMERIC HETEROCYCLIC COMPOUND AND USE THEREOF AS ANDROGEN RECEPTOR DEGRADER | Hinova Pharmaceuticals Inc. (CN) | 2024-06-05 | — | — | EP | claimed |
| EP-4376830-A1 | USE OF SGLT-2 INHIBITORS FOR THE PREVENTION AND/OR TREATMENT OF RENAL DISEASES IN NON-HUMAN MAMMALS | Boehringer Ingelheim Vetmedica GmbH (DE) | 2024-06-05 | — | — | EP | claimed |
| WO-2024088922-A1 | HETEROCYCLIC COMPOUNDS AS INHIBITORS OF MONOACYLGLYCEROL LIPASE (MAGL) | F. HOFFMANN-LA ROCHE AG (CH) | 2024-05-02 | — | — | WO | claimed |
| CN-117777121-A | Compounds and uses thereof | 詹森药业有限公司 | 2024-03-29 | — | — | CN | claimed |
| CN-117715640-A | Use of SGLT-2 inhibitors for preventing and/or treating heart diseases in non-human mammals excluding felines, particularly canines | 勃林格殷格翰动物保健有限公司 | 2024-03-15 | — | — | CN | claimed |
| CN-117715639-A | Use of SGLT-2 inhibitors for the prevention and/or treatment of kidney disease in non-human mammals | 勃林格殷格翰动物保健有限公司 | 2024-03-15 | — | — | CN | claimed |
| EP-3658539-B1 | COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY | NOVARTIS AG (CH) | 2024-02-21 | — | — | EP | claimed |
| US-20030187009-A1 | Analgesics, diarrhea, anticonvulsants, antitussive agents or drug abuse therapy | RENSSELAER POLYTECHNIC INSTITUTE | 2003-10-02 | — | — | US | claimed |
| EP-1335723-A1 | USE OF STIMULATORS OF SOLUBLE GUANYLATE CYCLASE FOR TREATING OSTEOPOROSIS | Bayer Aktiengesellschaft (DE) | 2003-08-20 | — | — | EP | claimed |
| WO-2003015770-A1 | NOVEL COMBINATION | BAYER HEALTHCARE AG (DE) | 2003-02-27 | — | — | WO | claimed |
| WO-2002036573-A2 | 8- SUBSTITUTED-2, 6-METHANO-3-BENZAZOCINES AND 3-SUBSTITUTED MORPHINANES AS OPIOID RECEPTOR BINDING AGENTS | RENSSELAER POLYTECHNIC INSTITUTE (US) | 2002-05-10 | — | — | WO | claimed |
| WO-2002036120-A1 | USE OF STIMULATORS OF SOLUBLE GUANYLATE CYCLASE FOR TREATING OSTEOPOROSIS | BAYER AKTIENGESELLSCHAFT (DE) | 2002-05-10 | — | — | WO | claimed |
| WO-2001047494-A1 | METHOD FOR CO-GRINDING SUBSTANCES AND LACTOSE BY MEANS OF JET MILS | BAYER AKTIENGESELLSCHAFT (DE) | 2001-07-05 | — | — | WO | claimed |
| EP-1102767-A1 | SUBSTITUTED PYRAZOLE DERIVATIVES | Bayer Aktiengesellschaft (DE) | 2001-05-30 | — | — | EP | claimed |
| WO-2000006568-A1 | SUBSTITUTED PYRAZOLE DERIVATIVES | BAYER AKTIENGESELLSCHAFT (DE) | 2000-02-10 | — | — | WO | claimed |
| US-4001218-A | BACTERICIDES | BAYER AKTIENGESELLSCHAFT (DT) | 1977-01-04 | — | — | US | claimed |
| US-3931153-A | BACTERICIDE | BAYER AKTIENGESELLSCHAFT (DT) | 1976-01-06 | — | — | US | claimed |